Amynon Biotech - Tumour Diagnostics in Motion
Amynon Biotech GmbH ist ein reines F&E Unternehmen und wurde Anfang 2002 als privates
Biotechnologieunternehmen in Innsbruck gegründet. Ziel der Amynon Biotech
ist die Entwicklung von Produkten, welche eine frühe Diagnose von
Tumorerkrankungen sowie krankhafter alters- und umweltassoziierter
Veränderungen ermöglichen.
Become a partner?
Want to reach amynon? Find out how partnering with amynon can help promote your business.
News
New competences for Amynon's team
Amynon could win two new scienific team members with high competence in protein biochemically processes and molecular biology.
Preclinical trial
After finalization of product optimization the first prototype of 'PapTec'- assay went into external preclinical trial with some austrian and german institutions. Aim is the proof of correlation between E7 oncoprotein detection, HPV testing, liquid based cytology and p16INK4a detection. Duration of the trial: 3 month.
» Archiv